Vitamin supplement use during breast cancer treatment and survival: A prospective cohort study

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 2, 2011, Pages 262-271

  Nechuta, Sarah ^a   Lu, Wei ^b   Chen, Zhi ^a   Zheng, Ying ^b   Gu, Kai ^b   Cai, Hui ^a   Zheng, Wei ^a   Shu, Xiao Ou ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Shanghai Institute of Preventive Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ASCORBIC ACID; MULTIVITAMIN; RETINOL; TAMOXIFEN; VITAMIN B GROUP; VITAMIN D;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CHINA; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; POPULATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SOCIAL ASPECT; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VITAMIN D; YOUNG ADULT;

EID: 79951643963     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1072     Document Type: Article

References (31)

1. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?J Natl Cancer Inst 2008;100:773-83.
2. Ladas EJ, Jacobson JS, Kennedy DD, Teel K, Fleischauer A, Kelly KM. Antioxidants and cancer therapy: a systematic review. J Clin Oncol 2004;22:517-28. (Pubitemid 41079781)
3. Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 2009;115:437-52.
4. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008;26:665-73. (Pubitemid 351264364)
5. Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999;4:304-29. (Pubitemid 29526338)
6. Fantappie O, Lodovici M, Fabrizio P, Marchettia S, Fabbroni V, Solazzo M, et al. Vitamin E protects DNA from oxidative damage in human hepatocellular carcinoma cell lines. Free Radic Res 2004;38:751-9. (Pubitemid 38812093)
7. Sakamoto K, Sakka M. Reduced effect of irradiation on normal and malignant cells irradiated in vivo in mice pretreated with vitamin E. Br J Radiol 1973;46:538-40.
8. Witenberg B, Kletter Y, Kalir HH, Raviv Z, Fenig E, Nagler A, et al. Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells. Radiat Res 1999;152:468-78. (Pubitemid 29514148)
9. Bairati I, Meyer F, Jobin E, Gelinas M, Fortin A, Nabid A, et al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006;119:2221-4. (Pubitemid 44423684)
10. Bairati I, Meyer F, Gelinas M, Fortin A, Nabid A, Brochet F, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005;97:481-8. (Pubitemid 40590429)
11. D'Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005;55:319-21. (Pubitemid 41377335)
12. Doyle C, Kushi LH, Byers T, Courneya KS, Demark-Wahnefried W, Grant B, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2006;56:323-53.
13. Hardy ML. Dietary supplement use in cancer care: help or harm. Hematol Oncol Clin N Am 2008;22:581-617. (Pubitemid 351970213)
14. Newman V, Rock CL, Faerber S, Flatt SW, Wright FA, Pierce JP, et al. Dietary supplement use bywomen at risk for breast cancer recurrence. J Am Diet Assoc 1998;98:285-92. (Pubitemid 28120083)
15. Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007;7:4.
16. Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO. The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med 2008;14:1049-55.
17. Greenlee H, Gammon MD, Abrahamson PE, Gaudet MM, Terry MB, Hershman DL, et al. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer 2009;115:3271-82.
18. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, et al. Soy food intake and breast cancer survival. JAMA 2009;302:2437-43.
19. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80. (Pubitemid 27009060)
20. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Jr, Montoye HJ, Sallis JF, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80. (Pubitemid 23027685)
21. Shah BR, Laupacis A, Hux JE, Austin PC. Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol 2005;58:550-9. (Pubitemid 40692720)
22. Bhutani M, Pathak AK. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?J Natl Cancer Inst 2008;100:1334; author reply 1335.
23. Poulter JM, White WF, Dickerson JW. Ascorbic acid supplementation and five year survival rates in women with early breast cancer. Acta Vitaminol Enzymol 1984;6:175-82. (Pubitemid 15198452)
24. Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast-cancer in high-risk patients supplemented with nutritional antioxidants, essential fatty-acids and coenzyme-Q(10). Mol Aspects Med 1994;15:231-40.
25. Hoffer A, Pauling L. Hardin Jones biostatistical analysis of mortality data for cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving these doses. J Orthomol Med 1990;5:143-54. (Pubitemid 20284873)
26. Hoffer A, Pauling L. Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving these doses. J Orthomol Med 1993;8:157-67. (Pubitemid 23327367)
27. Lesperance ML, Olivotto IA, Forde N, Zhao Y, Speers C, Foster H, et al. Mega-dose vitamins and minerals in the treatment of nonmetastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 2002;76:137-43. (Pubitemid 35252491)
28. Meyer F, Bairati I, Fortin A, Gelinas M, Nabid A, Brochet F, et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer 2008;122:1679-83. (Pubitemid 351294980)
29. Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML. Life After Cancer Epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United states). Cancer Cause Control 2005;16:545-56.
30. Ballard-Barbash R, Neuhouser ML. Challenges in design and interpretation of observational research on health behaviors and cancer survival. JAMA 2009;302:2483-4.
31. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, et al. The Shanghai Women's Health Study: Rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-31. (Pubitemid 41746625)